Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Yu-Ting Chou, PhD

Title(s)Associate Specialist, Medicine
SchoolSchool of Medicine
Address600 16th Street, #N216
San Francisco CA 94158
PronounsShe/Her/Hers
ORCID ORCID Icon0000-0001-8524-4220 Additional info
vCardDownload vCard

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Pan-RAF inhibitor exarafenib targets BRAF class II/III NSCLC and reveals ARAF-KSR1 resistance and combination strategies. Nat Commun. 2026 Feb 07; 17(1). Manabe T, Bergo HC, Li Q, Wang TS, Severson P, Miller N, Lee C, Yay Donderici E, Zhang N, Wu W, Chou YT, Kerr DL, Allegakoen P, Grandinetti KB, Soroceanu L, Pelham RJ, Martin ES, Murphy EA, Khanna V, Neal JW, Chen CT, Kato S, Williams R, Bivona TG. PMID: 41654519; PMCID: PMC12992618.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    2. Drug resistant cancer cells show increased nuclear mechanotransduction and mechanically targetable YAP-regulated vulnerability. Biomaterials. 2026 Jun; 329:123920. Huang M, Chen Y, Liang C, Narayan OP, Stallings C, Yu M, Traugot C, Li L, Li K, Vo Q, Wang H, Chou YT, Cech L, Parra D, Garzon L, Parsons D, Diaz E, Zhang C, Mackey C, Sussman H, Zmirska I, Chung M, Zhou C, Glynatsis G, Siemann DW, Licht JD, Li C, Kaye FJ, Xie M, Tan Y, Wu L, Bivona TG, Guan J, Tang X. PMID: 41443038; PMCID: PMC13179723.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. Role of hippocampal subfield volumes in the efficacy of transcranial direct current stimulation for late-life depression: An exploratory pilot randomized clinical trial. Behav Brain Res. 2026 03 05; 500:115963. Tseng CC, Lau CI, Chou YH, Yang KC, Cheng CM, Hu LY, Li CT, Tsai CF, Liu MN. PMID: 41319999.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Temporal photoproximity labeling of ligand-activated EGFR neighborhoods using MultiMap. Nat Chem Biol. 2026 Feb; 22(2):192-204. Lin Z, Ngo W, Chou YT, Wu H, Susa KJ, Jun YW, Bivona TG, Doudna JA, Wells JA. PMID: 41254216.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    5. Targeting Minimal Residual Disease. ANNUAL REVIEW OF CANCER BIOLOGY. 2025; 9:205-223. Yu-Ting Chou, Paul Allegakoen, and Trever G. Bivona. View Publication.
    6. Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer. Nat Commun. 2024 May 03; 15(1):3741. Haderk F, Chou YT, Cech L, Fernández-Méndez C, Yu J, Olivas V, Meraz IM, Barbosa Rabago D, Kerr DL, Gomez C, Allegakoen DV, Guan J, Shah KN, Herrington KA, Gbenedio OM, Nanjo S, Majidi M, Tamaki W, Pourmoghadam YK, Rotow JK, McCoach CE, Riess JW, Gutkind JS, Tang TT, Post L, Huang B, Santisteban P, Goodarzi H, Bandyopadhyay S, Kuo CJ, Roose JP, Wu W, Blakely CM, Roth JA, Bivona TG. PMID: 38702301; PMCID: PMC11068778.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansAnimalsCells
    7. Suppression of Ribose-5-Phosphate Isomerase a Induces ROS to Activate Autophagy, Apoptosis, and Cellular Senescence in Lung Cancer. Int J Mol Sci. 2022 Jul 17; 23(14). Nieh YC, Chou YT, Chou YT, Wang CY, Lin SX, Ciou SC, Yuh CH, Wang HD. PMID: 35887232; PMCID: PMC9322731.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    8. Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer. J Clin Invest. 2022 07 01; 132(13). Nanjo S, Wu W, Karachaliou N, Blakely CM, Suzuki J, Chou YT, Ali SM, Kerr DL, Olivas VR, Shue J, Rotow J, Mayekar MK, Haderk F, Chatterjee N, Urisman A, Yeo JC, Skanderup AJ, Tan AC, Tam WL, Arrieta O, Hosomichi K, Nishiyama A, Yano S, Kirichok Y, Tan DS, Rosell R, Okimoto RA, Bivona TG. PMID: 35579943; PMCID: PMC9246391.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    9. Inhibition of SHP2 as an approach to block RAS-driven cancers. Adv Cancer Res. 2022; 153:205-236. Chou YT, Bivona TG. PMID: 35101231.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    10. Kinase-mediated RAS signaling via membraneless cytoplasmic protein granules. Cell. 2021 05 13; 184(10):2649-2664.e18. Tulpule A, Guan J, Neel DS, Allegakoen HR, Lin YP, Brown D, Chou YT, Heslin A, Chatterjee N, Perati S, Menon S, Nguyen TA, Debnath J, Ramirez AD, Shi X, Yang B, Feng S, Makhija S, Huang B, Bivona TG. PMID: 33848463; PMCID: PMC8127962.
      View in: PubMed   Mentions: 109     Fields:    Translation:HumansCells
    11. A mammalian Wnt5a-Ror2-Vangl2 axis controls the cytoskeleton and confers cellular properties required for alveologenesis. Elife. 2020 05 12; 9. Zhang K, Yao E, Lin C, Chou YT, Wong J, Li J, Wolters PJ, Chuang PT. PMID: 32394892; PMCID: PMC7217702.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    12. Ribose-5-phosphate isomerase A overexpression promotes liver cancer development in transgenic zebrafish via activation of ERK and β-catenin pathways. Carcinogenesis. 2019 05 14; 40(3):461-473. Chou YT, Chen LY, Tsai SL, Tu HC, Lu JW, Ciou SC, Wang HD, Yuh CH. PMID: 30418535; PMCID: PMC6514454.
      View in: PubMed   Mentions: 22     Fields:    Translation:AnimalsCells
    13. Identification of a noncanonical function for ribose-5-phosphate isomerase A promotes colorectal cancer formation by stabilizing and activating β-catenin via a novel C-terminal domain. PLoS Biol. 2018 01; 16(1):e2003714. Chou YT, Jiang JK, Yang MH, Lu JW, Lin HK, Wang HD, Yuh CH. PMID: 29337987; PMCID: PMC5786329.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    14. Up-regulation of golgi α-mannosidase IA and down-regulation of golgi α-mannosidase IC activates unfolded protein response during hepatocarcinogenesis. Hepatol Commun. 2017 05; 1(3):230-247. Tu HC, Hsiao YC, Yang WY, Tsai SL, Lin HK, Liao CY, Lu JW, Chou YT, Wang HD, Yuh CH. PMID: 29404456; PMCID: PMC5721452.
      View in: PubMed   Mentions: 22     Fields:    
    15. Ribose-5-phosphate isomerase A regulates hepatocarcinogenesis via PP2A and ERK signaling. Int J Cancer. 2015 Jul 01; 137(1):104-15. Ciou SC, Chou YT, Liu YL, Nieh YC, Lu JW, Huang SF, Chou YT, Cheng LH, Lo JF, Chen MJ, Yang MC, Yuh CH, Wang HD. PMID: 25429733.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimalsCells
    16. P11 (S100A10) as a potential biomarker of psychiatric patients at risk of suicide. J Psychiatr Res. 2011 Apr; 45(4):435-41. Zhang L, Su TP, Choi K, Maree W, Li CT, Chung MY, Chen YS, Bai YM, Chou YH, Barker JL, Barrett JE, Li XX, Li H, Benedek DM, Ursano R. PMID: 20863517.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    17. Medically unexplained symptoms and somatoform disorders: diagnostic challenges to psychiatrists. J Chin Med Assoc. 2009 May; 72(5):251-6. Li CT, Chou YH, Yang KC, Yang CH, Lee YC, Su TP. PMID: 19467948.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    18. Duloxetine in treating medically unexplained pain and Raynaud's phenomenon. J Neuropsychiatry Clin Neurosci. 2009; 21(4):475-6. Li CT, Chou YH, Su TP. PMID: 19996264.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    Yu-Ting's Networks
    Concepts (125)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (18)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-34-g86efa0e9 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.